823 results on '"Good, Phillip"'
Search Results
2. Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer—a study protocol for a randomised controlled trial
3. The effects of OPRM1 118A>G on methadone response in pain management in advanced cancer at end of life
4. Exploring potential anti-inflammatory effects of medicinal cannabis
5. Defining research priorities and needs in cancer symptoms for adults diagnosed with cancer: an Australian/New Zealand modified Delphi study
6. The lived experience of end-stage cardiac failure
7. Psychological distress and physical symptoms in advanced cancer: cross-sectional study
8. Should subanaesthetic ketamine be considered when managing opioid refractory cancer pain?
9. Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer?
10. Association of KCNJ6 rs2070995 and methadone response for pain management in advanced cancer at end-of-life
11. Using a qualitative sub-study to inform the design and delivery of randomised controlled trials on medicinal cannabis for symptom relief in patients with advanced cancer
12. Drug dependence epidemiology in palliative care medicinal cannabis trials.
13. Evidence-based physiotherapy interventions: evaluation of current practice in a palliative care service.
14. Hopeful dying? The meanings and practice of hope in palliative care family meetings
15. Emotionally reflexive labour in end-of-life communication
16. Preliminary Results from a Phase IV Surveillance Study of Medical Cannabis Use in Australian Patients With Advanced Cancer Receiving Palliative Care
17. A community-embedded approach to increasing the health literacy of Aboriginal children in a regional area: processes of co-design and local implementation
18. Cannabinol oil or placebo in advanced cancer–disease progression and survival: a secondary analysis
19. Cannabidiol oil or placebo in advanced cancer-disease progression and survival: a secondary analysis.
20. The Impact of Provision of Professional Language Interpretation on Length of Stay and Readmission Rates in an Acute Care Hospital Setting
21. Impact of the COVID-19 pandemic on the use of an inpatient and community palliative care service.
22. Understanding priorities of care: An assessment of FAMCARE-2 satisfaction surveys and thematic analysis in community palliative care
23. Regular dosing compared with as-needed dosing of opioids for management of chronic cancer pain: systematic review and meta-analysis
24. Rates and Predictors of Professional Interpreting Provision for Patients With Limited English Proficiency in the Emergency Department and Inpatient Ward
25. Medically assisted hydration for adults receiving palliative care
26. Nursing futility, managing medicine : Nurses’ perspectives on the transition from life-prolonging to palliative care
27. Can Saliva and Plasma Methadone Concentrations Be Used for Enantioselective Pharmacokinetic and Pharmacodynamic Studies in Patients With Advanced Cancer?
28. Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)
29. Quantitative determination of the enantiomers of methadone in human plasma and saliva by chiral column chromatography coupled with mass spectrometric detection
30. Saliva versus Plasma for Pharmacokinetic and Pharmacodynamic Studies of Fentanyl in Patients with Cancer
31. Drug dependence epidemiology in palliative care medicinal cannabis trials
32. Corticosteroids for the management of cancer-related fatigue in adults with advanced cancer
33. The Effect of Methylphenidate on Fatigue in Advanced Cancer: An Aggregated N-of-1 Trial
34. Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD)
35. ‘What price do you put on your health?’: Medical cannabis, financial toxicity and patient perspectives on medication access in advanced cancer
36. On resilience and acceptance in the transition to palliative care at the end of life
37. Testing a Hypothesis
38. Estimation
39. Descriptive Statistics
40. Categorical Data
41. Multiple Variables and Multiple Hypotheses
42. Experimental Design and Analysis
43. Power of a Test
44. Hypothesis Testing
45. When the Distribution Is Known
46. Model Building
47. Which Statistic Should I Use?
48. Publishing Your Results
49. Experimental Designs
50. Clustering in Time and Space
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.